Condition: Artificial Intelligence (AI) · Artificial Intelligence (AI) in Diagnosis · Hypertension, Pulmonary · Sponsor: National Defense Medical Center, Taiwan
This study aims to validate the use of an artificial intelligence-enabled electrocardiogram (AI-ECG) to screen for elevated PAP. We hypothesize that the AI-ECG model can early identify patients with pulmonary hypertension in high-risk patients, prompting further evaluation through echocardiography, potentially resulting in improving cardiovascular outcomes.
This description comes directly from the study's public registry record.
Chin Lin, Associate Professor · 886+2-87923311 · up6fup0629@gmail.com
Always discuss trial participation with your own doctor first.
| National Defense Medical Center | Taipei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07079592